Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats

Tullio Florio, Olimpia Meucci, Maurizio Grimaldi, Carmelo Ventra, Eleonora Cocozza, Antonio Avallone, Alfredo Postiglione, Adriano Marino, Gennaro Schettini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The aim of the present study has been to evaluate the effect of acetyl-l-carnitine (ALCAR) on brain adenylate cyclase (AC) activity in adult and aged rats. In in vitro studies, ALCAR (1, 10 and 100 μM) did not exert any effect on frontal cortex basal AC activity. Acute and subchronic administrations of ALCAR were carried out in 4- and 25-month-old male Fisher rats and AC activity was determined in rat frontal cortex under both basal and stimulated conditions. The acute treatment of young rats with ALCAR (100 and 500 mg/kg s.c.) did not affect AC activity, whereas the subchronic administration of 250 mg/kg s.c. ALCAR enhanced the stimulation of AC by carbamylcholine (CCh), norepinephrine (NE) and dopamine (DA), without affecting the basal AC activity. Basal AC activity in old rats was lower than in young rats and was not modified by acute and subchronic ALCAR administration. Moreover, the response of the enzyme to CCh, NE and DA was potentiated by the subchronic administration of ALCAR. The concentration-response curve of CCh stimulation of AC activity in ALCAR-treated rats is shifted to the left in both young and aged rats. We conclude that ALCAR, subchronically administered, is able to enhance receptor-stimulated AC response in frontal cortex of both young and aged rats.

Original languageEnglish
Pages (from-to)95-101
Number of pages7
JournalEuropean Neuropsychopharmacology
Volume3
Issue number2
DOIs
Publication statusPublished - 1993

Fingerprint

Acetylcarnitine
Adenylyl Cyclases
Brain
Carbachol
Frontal Lobe
Dopamine
Norepinephrine

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Pharmacology
  • Psychology(all)

Cite this

Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats. / Florio, Tullio; Meucci, Olimpia; Grimaldi, Maurizio; Ventra, Carmelo; Cocozza, Eleonora; Avallone, Antonio; Postiglione, Alfredo; Marino, Adriano; Schettini, Gennaro.

In: European Neuropsychopharmacology, Vol. 3, No. 2, 1993, p. 95-101.

Research output: Contribution to journalArticle

Florio, T, Meucci, O, Grimaldi, M, Ventra, C, Cocozza, E, Avallone, A, Postiglione, A, Marino, A & Schettini, G 1993, 'Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats', European Neuropsychopharmacology, vol. 3, no. 2, pp. 95-101. https://doi.org/10.1016/0924-977X(93)90260-S
Florio, Tullio ; Meucci, Olimpia ; Grimaldi, Maurizio ; Ventra, Carmelo ; Cocozza, Eleonora ; Avallone, Antonio ; Postiglione, Alfredo ; Marino, Adriano ; Schettini, Gennaro. / Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats. In: European Neuropsychopharmacology. 1993 ; Vol. 3, No. 2. pp. 95-101.
@article{06dbec825688425ab00c362c89e68630,
title = "Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats",
abstract = "The aim of the present study has been to evaluate the effect of acetyl-l-carnitine (ALCAR) on brain adenylate cyclase (AC) activity in adult and aged rats. In in vitro studies, ALCAR (1, 10 and 100 μM) did not exert any effect on frontal cortex basal AC activity. Acute and subchronic administrations of ALCAR were carried out in 4- and 25-month-old male Fisher rats and AC activity was determined in rat frontal cortex under both basal and stimulated conditions. The acute treatment of young rats with ALCAR (100 and 500 mg/kg s.c.) did not affect AC activity, whereas the subchronic administration of 250 mg/kg s.c. ALCAR enhanced the stimulation of AC by carbamylcholine (CCh), norepinephrine (NE) and dopamine (DA), without affecting the basal AC activity. Basal AC activity in old rats was lower than in young rats and was not modified by acute and subchronic ALCAR administration. Moreover, the response of the enzyme to CCh, NE and DA was potentiated by the subchronic administration of ALCAR. The concentration-response curve of CCh stimulation of AC activity in ALCAR-treated rats is shifted to the left in both young and aged rats. We conclude that ALCAR, subchronically administered, is able to enhance receptor-stimulated AC response in frontal cortex of both young and aged rats.",
author = "Tullio Florio and Olimpia Meucci and Maurizio Grimaldi and Carmelo Ventra and Eleonora Cocozza and Antonio Avallone and Alfredo Postiglione and Adriano Marino and Gennaro Schettini",
year = "1993",
doi = "10.1016/0924-977X(93)90260-S",
language = "English",
volume = "3",
pages = "95--101",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier Science B.V.",
number = "2",

}

TY - JOUR

T1 - Effect of acetyl-l-carnitine treatment on brain adenylate cyclase activity in young and aged rats

AU - Florio, Tullio

AU - Meucci, Olimpia

AU - Grimaldi, Maurizio

AU - Ventra, Carmelo

AU - Cocozza, Eleonora

AU - Avallone, Antonio

AU - Postiglione, Alfredo

AU - Marino, Adriano

AU - Schettini, Gennaro

PY - 1993

Y1 - 1993

N2 - The aim of the present study has been to evaluate the effect of acetyl-l-carnitine (ALCAR) on brain adenylate cyclase (AC) activity in adult and aged rats. In in vitro studies, ALCAR (1, 10 and 100 μM) did not exert any effect on frontal cortex basal AC activity. Acute and subchronic administrations of ALCAR were carried out in 4- and 25-month-old male Fisher rats and AC activity was determined in rat frontal cortex under both basal and stimulated conditions. The acute treatment of young rats with ALCAR (100 and 500 mg/kg s.c.) did not affect AC activity, whereas the subchronic administration of 250 mg/kg s.c. ALCAR enhanced the stimulation of AC by carbamylcholine (CCh), norepinephrine (NE) and dopamine (DA), without affecting the basal AC activity. Basal AC activity in old rats was lower than in young rats and was not modified by acute and subchronic ALCAR administration. Moreover, the response of the enzyme to CCh, NE and DA was potentiated by the subchronic administration of ALCAR. The concentration-response curve of CCh stimulation of AC activity in ALCAR-treated rats is shifted to the left in both young and aged rats. We conclude that ALCAR, subchronically administered, is able to enhance receptor-stimulated AC response in frontal cortex of both young and aged rats.

AB - The aim of the present study has been to evaluate the effect of acetyl-l-carnitine (ALCAR) on brain adenylate cyclase (AC) activity in adult and aged rats. In in vitro studies, ALCAR (1, 10 and 100 μM) did not exert any effect on frontal cortex basal AC activity. Acute and subchronic administrations of ALCAR were carried out in 4- and 25-month-old male Fisher rats and AC activity was determined in rat frontal cortex under both basal and stimulated conditions. The acute treatment of young rats with ALCAR (100 and 500 mg/kg s.c.) did not affect AC activity, whereas the subchronic administration of 250 mg/kg s.c. ALCAR enhanced the stimulation of AC by carbamylcholine (CCh), norepinephrine (NE) and dopamine (DA), without affecting the basal AC activity. Basal AC activity in old rats was lower than in young rats and was not modified by acute and subchronic ALCAR administration. Moreover, the response of the enzyme to CCh, NE and DA was potentiated by the subchronic administration of ALCAR. The concentration-response curve of CCh stimulation of AC activity in ALCAR-treated rats is shifted to the left in both young and aged rats. We conclude that ALCAR, subchronically administered, is able to enhance receptor-stimulated AC response in frontal cortex of both young and aged rats.

UR - http://www.scopus.com/inward/record.url?scp=0027882534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027882534&partnerID=8YFLogxK

U2 - 10.1016/0924-977X(93)90260-S

DO - 10.1016/0924-977X(93)90260-S

M3 - Article

C2 - 8364354

AN - SCOPUS:0027882534

VL - 3

SP - 95

EP - 101

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 2

ER -